Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor version upgrade with no visible impact on study details.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 on the page footer; no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedMinor UI and metadata updates were made: the glossary is now shown, the page revision was updated to v3.4.0, and QC/FEAR Act data labels were added or adjusted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page's Locations section has been updated to include numerous new sites across the United States and international locations (Australia, Canada, Japan, and others). The geographic coverage of listed study sites appears expanded.SummaryDifference2%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.